X. Tong

Population Pharmacokinetic and Exposure‐Response Analysis of Selumetinib and Its N‐desmethyl Metabolite in Patients With Non‐Small Cell Lung Cancer

Diansong Zhou, H. Tomkinson, Hongmei Xu, 2018, Journal of clinical pharmacology.

Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study

Diansong Zhou, Hongmei Xu, N. Al-Huniti, 2019, Basic & clinical pharmacology & toxicology.

Determination of vancomycin pharmacokinetic/pharmacodynamic target and individualized dosing regimen recommendation in ICU neonates

Y. Yu, J. Li, Z. Jiao, 2020, medRxiv.

Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy

Diansong Zhou, J. Mullen, Hongmei Xu, 2018, Journal of clinical pharmacology.

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque–removing agent, in patients with Alzheimer’s disease

I. Nestorov, K. Kowalski, R. Rajagovindan, 2021, CPT: pharmacometrics & systems pharmacology.